Iron Deficiency in the Absence of Anemia - A Common, Complex and Challenging Disease to Treat

Main Article Content

Esa Soppi, MD, PhD,


Iron deficiency in absence of anemia and blood count changes is a common disorder. Since iron is an essential cofactor not only of hemoglobin and myoglobin but also of numerous enzymes fundamental for many biological processes, it is understandable that the spectrum of iron deficiency related symptoms may be complex, severe and difficult to associate with iron deficiency. This often leads to significant diagnostic delays and a multitude of misleading diagnoses and treatments. Therefore, considering a diagnosis of iron deficiency without anemia requires a high degree of alertness. The second step in the diagnostic process, following consideration of the possibility of iron deficiency, is a careful history that covers all potential causes of deficient iron stores since the patient’s birth and beyond combined by the appropriate investigations. The ferritin concentration is key for ascertaining the diagnosis. A ferritin concentration of less than 30 µg/L in a symptomatic individual means iron deficiency, but the patient may be iron deficient with much higher ferritin concentrations. Simultaneous determination of C-reactive protein with ferritin is practically useless. The treating physician should be familiar with the complexity of ferritin determinations and the interpretation of the results. The mainstay of treatment is oral iron but a considerable proportion of patients are intolerant or insufficiently responsive to oral iron and require intravenous iron therapy. The longer the duration of the iron deficiency, the more complicated the treatment and the patient’s recovery may become. For some patients, iron deficiency seems to be a chronic disorder requiring management exceeding 5 years. In 1–5% of patients, particularly those with a duration of iron deficiency in absence of anemia of more than 15–25 years, the restoration of iron stores does not lead to clinical recovery within 5 years of follow-up. Iron deficiency without anemia has a high impact on the well-being and quality of life of the affected individuals and impacts significantly also on society, since the challenges in recognition, diagnosis and treatment of the condition generate costs probably in excess of 100 million euros/5 million inhabitants.


Article Details

How to Cite
SOPPI, Esa. Iron Deficiency in the Absence of Anemia - A Common, Complex and Challenging Disease to Treat. Medical Research Archives, [S.l.], v. 10, n. 10, oct. 2022. ISSN 2375-1924. Available at: <>. Date accessed: 27 may 2024. doi:
Research Articles


1. Camaschella C. Iron deficiency. Blood. 2019;133(1):30-39.
2. Al-Jafar HA. HWA: Hypoferritinemia without anemia a hidden hematology disorder. J Family Med Prim Care. 2017;6(1):69-72. doi.10.4103/2249-4863.214986
3. Goodnough LT, Nemeth E. Iron deficiency and related disorders. 615-643. Greer JP, Arber DA, Glader BE, List AF, Means RT, Rodgers GM (eds). In Wintrobe’s Clinical Hematology, 14th edition. Wolters Kluwer Health. 2018.
4. Soppi E. Iron deficiency without anemia – common, important, neglected. Clin Case Rep Rev. 2019;5(1):1-7. doi.10.15761/CCRR.1000456
5. Al-Naseem A, Sallam, A, Shamim Choudhury S, Thachil J. Iron deficiency without anaemia: a diagnosis that matters. Clin Med. (Lond) 2021;21(2):107–113. doi.10.7861/clinmed.2020-0582
6. Dallman, PR, Beutler E, Finch CA. Effects of iron de¬ficiency exclusive of anaemia. Br J Haematol. 1978;40(2):179-184. doi.10.1111/j.1365-2141.1978.tb03655.x
7. Soppi E. Iron deficiency without anaemia - a clinical challenge. Clinical Case Rep . 2018;6(6):1082–1086. doi.10.1002/ccr3.1529.
8. Ravanbod M, Asadipooya K, Kalantarhormozi M, Nabipour I, Omrani GR. Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism. Am J Med. 2013;126(5):420-424. doi.10.1016/j.amjmed.2012.12.009
9. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. doi.10.1056/NEJMra1401038
10. Harju E, Pakarinen A, Larmi T. A comparison between serum ferritin concentration and the amount of bone marrow stainable iron. Scand J Clin Lab Invest. 1984;44(6): 555–556. doi.10.1080/00365518409083610
11. Mast AE, Blinder MA, Gronowski, AM, Chumley C, Scott M. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44(1):45–51.
12. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Helmut Drexler H, Thomas F. Lüscher, TF, Bart B, Banasiak W, Niegowska J, Kirwan B-A, Mori C, et al., for the FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2019;361(25):2436-2448. doi.10.1056/NEJMoa0908355
13. Galetti V, Stoffel NU, Sieber C, Zeder C, Diego Moretti D, Zimmermann MB. Threshold ferritin and hepcidin concentrations indicating early iron deficiency in young women based on upregulation of iron absorption. EClinicalMedicine. 2021;39:101052. doi.10.1016/j.eclinm.2021.101052
14. Moran-Lev H, Weisman Y, Cohen S, Deutsch V, Cipok M, Bondar E, Lubetzky R, Mandel D. The interrelationship between hepcidin, vitamin D, and anemia in children with acute infectious disease. Pediatr Res. 2018;84(1):62–65. doi.10.1038/s41390-018-0005-0
15. Soppi E. Intravenous iron – personal experience of 1000 consecutive infusions. Clin Case Rep Rev. 2020;6(1):1-6. doi.10.15761/CCRR.1000492
16. Castelo-Branco C, Quintas L. Iron deficiency without anemia: indications for treatment. Gynecol Repro Endocrinol Metabol. 2020;1(4):215-222.
17. Paul BT, Manz DH, Torti FM, Torti SV. Mitochondria and iron: Current questions. Expert Rev Hematol. 2017;10(1):65–79. doi.10.1080/17474086.2016.1268047
18. Rineau E, Gueguen N, Procaccio V, Geneviève F, Reynier P, Henrion D, Lasocki S. Iron deficiency without anemia decreases physical endurance and mitochondrial complex I activity of oxidative skeletal muscle in the mouse. Nutrients. 2021;13(4):1056-1065. doi.10.3390/nu13041056.
19. Bener A, Kamal M, Bener HZ, Bhugra D. Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children. Ann Med Health Sci Res. 2014;4(3):291-297. doi.10.4103/2141-9248.141974
20. Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. Am J Clin Nutr. 2009;89(suppl):946S–50S. doi.10.3945/ajcn.2008.26692D
21. Yao W-C, Chen H-J, Leong K-H, Chang K-L, Wang Y-T T, Wu L-C, Tung P-Y, Kuo C-F, Lin C-C, Tsai S-Y. The risk of fibromyalgia in patients with iron deficiency anemia: a nationwide population based cohort study. Sci Rep. 2021;11:10496-10513. doi.10.1038/s41598-021-89842-9
22. Catassi C, Alaedini A, Bojarski C, Bonaz B, Bouma G, Carroccio A, Castillejo G, De Magistris L, Dieterich W, Di Liberto D, Elli L, Fasano A, Hadjivassiliou M, Kurien M, Lionetti E, Mulder CJ, Rostami K, Sapone A, Scherf K, Schuppan D, Trott N, Volta U, Zevallos V, Zopf Y, Sanders DS. The Overlapping area of non-celiac gluten sensitivity (NCGS) and wheat-sensitive irritable bowel syndrome (IBS): An update. Nutrients. 2017;9(11):1268-1273. doi.10.3390/nu9111268
23. Burton C, Fink P, Henningsen P, Löwe B, Rief W, on behalf of the EURONET-SOMA Group. Functional somatic disorders: discussion paper for a new common classification for research and clinical use. BMC Medicine. 2020;18:34-40. doi.10.1186/s12916-020-1505
24. Aybek S, Perez DL. Diagnosis and management of functional neurological disorder. BMJ. 2022;376:o64-o73. doi.10.1136/bmj.o64
25. Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA. 2019;322(6):499-500. doi.10.1001/jama.2019.831
26. Sezgin G, Monagle P, Loh TP, Ignjatovic V, Hoq M, Pearce C, McLeod A; Westbrook J, Li L, Georgiou A. Clinical thresholds for diagnosing iron deficiency: comparison of functional assessment of serum ferritin to population-based centiles. Sci Rep. 2020;10:18233-18244. doi.10.1038/s41598-020-75435-5
27. Fletcher A, Forbes A, Svenson N, Thomas DW, on behalf of and A British Society for Haematology Good Practice Paper. Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children. Br J Haematol. 2022;196(3):523–529. doi.10.1111/bjh.17900
28. Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020;105(2):260-272. doi.10.3324/haematol.2019.232124
29. Pasricha S-R, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood E. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 2011;96(8):1099–1105. doi.10.3324/haematol.2010.037960
30. Litton E, Baker S, Erber W, Farmer S, FerrierJ, French C, Gummer J, Hawkins D, Alisa Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S, on behalf of the IRONMAN Study investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study. J Intens Care. 2018;6(1):60-66.
31. Soppi E. Iron is hard stuff. A book in Finnish, 193 pages. M.I.T. Consulting Ltd. 2020.
32. Lozoff B, Smith JB, Kaciroti N, Clark KM, Guevara S, Jimenez E. Functional significance of early-life iron deficiency: outcomes at 25 years. J Pediatr. 2013;163(5):1260-1266. doi.10.1016/j.jpeds.2013.05.015
33. Stabell N, Averina M, Flægstad T. Chronic iron deficiency and anaemia were highly prevalent in a population-based longitudinal study among adolescent girls. Acta Paediatrica. 2021;110(10):2842–2849. doi.10.1111/apa.16016